The effectiveness of 1-[(5-nitrofuran-2-yl)carbonyl]-2’-cyclohexyl-1h,7’h-spiro[azetidin-3,5’-furo[3,4-d]pyrimidin] in experimental tuberculosis of C57BL/6 mice infected with mycobacteria of various biological properties
Abstract
The purpose of this study is to investigate the effective-ness of a new substance, LK1676, from the series of nitro-heterocyclic compounds, which has in vitro antitubercu-losis activity against drug-sensitive (DS) and drug-resistant (DR) Mycobacterium tuberculosis strains, in the context of monotherapy for experimental tuberculosis infection. C57BL/6 mice were inoculated into the tail vein with a sus-pension of LK1676, an international virulent test strain of M. tuberculosis H37Rv, or a clinical strain of M. tuberculosis of the Beijing genotype with multiple drug resistance (MDR). LK1676 was administered for 6 weeks as a mono-therapy per os at a dose of 10 mg/kg, while the comparison drugs were pyrazinamide (Z) ethambutol (E), moxifloxacin (Mfx), and linezolid (Lzd) at therapeutic doses. The effec-tiveness of the therapy was evaluated using biometric, bacteriological, and histological methods. Monotherapy of LK1676 mice infected with the HPV strain M. tuberculosisH37Rv reduced the bacterial load in the lungs (p<0.03), biometric parameters of the lungs (p<0.005) and spleen (p<0.007), the prevalence of specific lesions in lung tissue, the disappearance of signs of destruction, increased lo-cal lung immunity in terms of severity of perivascular and peribronchial infiltration, as well as the cellular composi-tion of the inducible bronchoassociated lymphoid tissue (iBALT). The efficacy of LK1676 was comparable to that of Mfx and Z, but significantly lower than that of E.…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.